Esperion Therapeutics
ESPR
#8346
Rank
ยฃ0.12 B
Marketcap
ยฃ0.65
Share price
-1.91%
Change (1 day)
-61.98%
Change (1 year)

Esperion Therapeutics (ESPR) - P/B ratio

P/B ratio as of April 2025 : -0.4492

According to Esperion Therapeutics's latest financial reports the company has a price-to-book ratio of 0.525493.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Esperion Therapeutics - P/B ratio (from 2013 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31-1.1654.65%
2023-12-31-0.7473-47.29%
2022-12-31-1.42-8.3%
2021-12-31-1.55-77.94%
2020-12-31-7.01-108.53%
2019-12-3182.2426.99%
2018-12-3115.6121.25%
2017-12-317.05470.68%
2016-12-311.24-29.21%
2015-12-311.74-71.67%
2014-12-316.16116.53%
2013-12-312.84
2012-12-31N/A
2003-12-31N/A
2002-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
13.5-3,099.46%๐Ÿ‡บ๐Ÿ‡ธ USA
2.13-573.31%๐Ÿ‡บ๐Ÿ‡ธ USA
1.46-424.97%๐Ÿ‡บ๐Ÿ‡ธ USA
2.23-597.23%๐Ÿ‡บ๐Ÿ‡ธ USA
11.4-2,637.65%๐Ÿ‡บ๐Ÿ‡ธ USA
1.75-489.62%๐Ÿ‡บ๐Ÿ‡ธ USA